Cargando…

Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer

TAS-106, a RNA polymerase inhibitor, was studied in solid tumors with potential clinical benefit and reasonable tolerability. We conducted a multicenter, international phase II trial of TAS-106 in salvage metastatic or recurrent head and neck squamous cell cancer (HNSCC) and nasopharyngeal cancer (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsao, Anne, Hui, Edwin Pun, Juergens, Rosalyn, Marur, Shanthi, Huat, Tan Eng, Cher, Goh Boon, Hong, Ruey-Long, Hong, Waun Ki, Chan, Anthony Tak-Cheung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699847/ https://www.ncbi.nlm.nih.gov/pubmed/23930212 http://dx.doi.org/10.1002/cam4.79

Ejemplares similares

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
por: Naing, Aung, et al.
Publicado: (2013)

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
por: Shimamoto, Yuji, et al.
Publicado: (2002)

Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2
por: Shimamoto, Yuji, et al.
Publicado: (2002)

Beyond the Platinum Era—Scalable Preparation and Electrochemical Activation of TaS(2) Flakes
por: Buravets, Vladislav, et al.
Publicado: (2023)

Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine
por: Shimamoto, Yuji, et al.
Publicado: (2001)

Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo
por: Yasui, H, et al.
Publicado: (2008)

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma
por: Lim, Darren Wan-Teck, et al.
Publicado: (2023)

New values of a type 2 taste receptor TAS2R14 in thyroid cancer: New values of TAS2R14 in thyroid cancer
por: Liu, Lianyong, et al.
Publicado: (2022)

The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
por: Coschi, Courtney H., et al.
Publicado: (2021)

Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in Singapore
por: Mak, Han Wen, et al.
Publicado: (2015)

Shieldings: TAS
Publicado: (2004)

Shieldings: TAS
Publicado: (2004)

Cost-effectiveness of TAS-102 plus bevacizumab versus TAS-102 monotherapy in patients with metastatic colorectal cancer
por: Sugiura, Kiyoaki, et al.
Publicado: (2021)

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
por: Iafolla, Marco A. J., et al.
Publicado: (2017)

Vanillin Activates Human Bitter Taste Receptors TAS2R14, TAS2R20, and TAS2R39
por: Morini, Gabriella, et al.
Publicado: (2021)

A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Xiaochen, et al.
Publicado: (2021)

Tas chebal : jun chajp a'tel pajbil /
por: González Dillon, Mónica
Publicado: (2013)

Complete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinoma
por: Lau, Chi Pan, et al.
Publicado: (2009)

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
por: Tsao, Anne S., et al.
Publicado: (2016)

TAS-102, the first “cardio-gentle” fluoropyrimidine in the colorectal cancer landscape?
por: Petrelli, Fausto, et al.
Publicado: (2016)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
por: Liu, Cheng-Jiang, et al.
Publicado: (2021)

Profiling of 3D Genome Organization in Nasopharyngeal Cancer Needle Biopsy Patient Samples by a Modified Hi-C Approach
por: Animesh, Sambhavi, et al.
Publicado: (2021)

A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression
por: Meike, Shunsuke, et al.
Publicado: (2011)

Colorectal Cancer Migration and Invasion Initiated by microRNA-106a
por: Feng, Bo, et al.
Publicado: (2012)

Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
por: Ding, Yuxun, et al.
Publicado: (2021)

Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells
por: Seo, Yoona, et al.
Publicado: (2017)

Energy Deposition in the Triplet and TAS Issues
por: Broggi, F
Publicado: (2008)

Implementation of TasP: challenges and opportunities
por: Lange, Joep
Publicado: (2014)

TAS-102 and the quest for predictive biomarkers
por: van der Velden, Daphne L, et al.
Publicado: (2017)

MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma
por: Zhu, Qingwen, et al.
Publicado: (2020)

Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer
por: Barontini, Jonathan, et al.
Publicado: (2017)

Exosomal miR‐106a‐5p accelerates the progression of nasopharyngeal carcinoma through FBXW7‐mediated TRIM24 degradation
por: Li, Chang‐Wu, et al.
Publicado: (2022)

Unusual Paraneoplastic Presentation of Cholangiocarcinoma
por: Opneja, Aman, et al.
Publicado: (2015)

Correction: Colorectal Cancer Migration and Invasion Initiated by microRNA-106a
por: Feng, Bo, et al.
Publicado: (2012)

Tunable Contact Types and Interfacial Electronic Properties in TaS(2)/MoS(2) and TaS(2)/WSe(2) Heterostructures
por: Zhu, Xiangjiu, et al.
Publicado: (2023)

Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
por: Yu, Fenggang, et al.
Publicado: (2021)

Exosomal transfer of miR‐106a‐5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma
por: Li, Jiaxing, et al.
Publicado: (2021)

Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Zhu, Yunshu, et al.
Publicado: (2020)

Members of Bitter Taste Receptor Cluster Tas2r143/Tas2r135/Tas2r126 Are Expressed in the Epithelium of Murine Airways and Other Non-gustatory Tissues
por: Liu, Shuya, et al.
Publicado: (2017)

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
por: Melosky, Barbara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_at3nm1rr5e1soaaof9ajkj07pi